Activation of the PI3K-AKT pathway in human malignant mesothelioma cells

作者：Suzuki Yutaro; Murakami Hideki; Kawaguchi Koji; Taniguchi Tetsuo; Fujii Makiko; Shinjo Keiko; Kondo Yutaka; Osada Hirotaka; Shimokata Kaoru; Horio Yoshitsugu; Hasegawa Yoshinori; Hida Toyoaki; Sekido Yoshitaka^*

来源：Molecular Medicine Reports, 2009, 2(2): 181-188.

DOI：10.3892/mmr_00000081

• malignant mesothelioma
• phosphatidylinositol 3-kinase
• AKT
• PTEN

Malignant mesothelioma (MM) is a highly aggressive neoplasm, which is associated with asbestos exposure. The dysregulated phosphatidylinositol 3-kinase (PI3K)-AKT pathway plays an important role in cell proliferation, survival and motility in various cancers. In this study, we analyzed the activation status and underlying mechanisms of this pathway in MM cells using 21 cell lines. AKT activation was observed in 13 (62%) of the 21 MM cell lines under serum-starved conditions. Two cell lines, ACC-MESO-1 and Y-MESO-25, showed no expression of PTEN protein, while 7 other cell lines showed low expression of PTEN mRNA and protein compared to expression levels in an immortalized normal mesothelial cell line, MeT-5A. We found that PTEN inactivation in the ACC-MESO-1 and Y-MESO-25 lines was due to a 39.4-kb deletion including PTEN exon 2, and to a 7.7-kb deletion including exon I, respectively. Re-expression of PTEN in these cells reduced the activity of colony formation in vitro. In contrast, no mutation of PIK3CA or LKB1 was found in any of the MM cell lines. These findings suggest that AKT is frequently activated in MM cells, in part due to the downregulation of PTEN. Thus, the PI3K-AKT signaling pathway is a potential therapeutic target for MM.

• 出版日期2009-4